1921
Volume 84, Issue 2_Suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Preview this article:
Zoom in
Zoomout

Vaccine Research: Insights from Colombian Studies, Page 1 of 1

| /docserver/preview/fulltext/14761645/84/2_Suppl/01-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2011.09-0781
2011-02-04
2020-07-16
Loading full text...

Full text loading...

/deliver/fulltext/14761645/84/2_Suppl/01.html?itemId=/content/journals/10.4269/ajtmh.2011.09-0781&mimeType=html&fmt=ahah

References

  1. Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97106.
    [Google Scholar]
  2. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, 2007. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 7987.
    [Google Scholar]
  3. 2006. Malaria Vaccine Technology Roadmap. Available at: http://www.malariavaccine.org/files/Malaria_Vaccine_TRM_Final.pdf.
    [Google Scholar]
  4. Herrera S, Corradin G, Arévalo-Herrera M, 2007. An update on the search for a Plasmodium vivax vaccine. Trends Parasitol 23: 122128.[Crossref]
    [Google Scholar]
  5. Guerra CA, Snow RW, Hay SI, 2006. Mapping the global extent of malaria in 2005. Trends Parasitol 22: 353358.[Crossref]
    [Google Scholar]
  6. Yeom JS, Kim TS, Oh S, Sim JB, Barn JS, Kim HJ, Kim YA, Ahn SY, Shin MY, Yoo JA, Park JW, 2007. Plasmodium vivax malaria in the Republic of Korea during 2004–2005: changing patterns of infection. Am J Trop Med Hyg 76: 865868.
    [Google Scholar]
  7. Faulde MK, Hoffmann R, Fazilat KM, Hoerauf A, 2007. Malaria reemergence in northern Afghanistan. Emerg Infect Dis 13: 14021404.[Crossref]
    [Google Scholar]
  8. Aramburu Guarda J, Ramal Asayag C, Witzig R, 1999. Malaria reemergence in the Peruvian Amazon region. Emerg Infect Dis 5: 209215.[Crossref]
    [Google Scholar]
  9. PAHO, 2003. Informe de la situación de los programas de malaria en las Américas. Available at: http://www.paho.org/Spanish/AD/DPC/CD/programas-nacionales.pdf.
    [Google Scholar]
  10. Joshi H, Prajapati SK, Verma A, Kang'a S, Carlton JM, 2008. Plasmodium vivax in India. Trends Parasitol 24: 228235.[Crossref]
    [Google Scholar]
  11. Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R, 2003. The paroxysm of Plasmodium vivax malaria. Trends Parasitol 19: 188193.[Crossref]
    [Google Scholar]
  12. Ozen M, Gungor S, Atambay M, Daldal N, 2006. Cerebral malaria owing to Plasmodium vivax: case report. Ann Trop Paediatr 26: 141144.[Crossref]
    [Google Scholar]
  13. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A, 2005. Plasmodium vivax malaria. Emerg Infect Dis 11: 132134.[Crossref]
    [Google Scholar]
  14. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN, 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.[Crossref]
    [Google Scholar]
  15. Price L, Planche T, Rayner C, Krishna S, 2007. Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Trans R Soc Trop Med Hyg 101: 655659.[Crossref]
    [Google Scholar]
  16. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN, 2008. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 46: 13741381.[Crossref]
    [Google Scholar]
  17. Valderrama-Aguirre A, Quintero G, Gomez A, Castellanos A, Perez Y, Mendez F, Arévalo-Herrera M, Herrera S, 2005. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 Pv200L: a potential malaria vaccine subunit. Am J Trop Med Hyg 73: 1624.
    [Google Scholar]
  18. Herrera SB, Perlaza BL, Fernández OL, Victoria L, Lenis AM, Soto L, Hurtado H, Acuña LM, Vélez JD, Palacios R, Chen-Mok M, Corradin G, Arévalo-Herrera M, 2005. Safety and elicitation of humoral and cellular responses in Colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. Am J Trop Med Hyg 73 (Suppl): 39.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.09-0781
Loading
  • Received : 15 Dec 2009
  • Accepted : 23 Dec 2009
  • Published online : 04 Feb 2011
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error